Talenom as an investment

Outlook and guidance

Outlook and guidance

New financial guidance for 2025 (issued on 15 December 2025):

Talenom estimates that 2025 net sales will be around EUR 129–131 million and EBITDA around EUR 33–35 million including the costs arising from the strategic review, separation and listing.

Read the full release from below.


Previous financial guidance for 2025 (issued on 13 December 2024):

Talenom estimates that 2025 net sales will be around EUR 130–140 million and EBITDA around EUR 36–42 million.

Financial guidance for 2026

The outlook for 2026 is described in the stock exchange release below.